Clinical trial Recruiting at 1 site Interventional Ages 18 to 60 Women only

Preventing postpartum diabetes in women with gestational diabetes

Official title: Gestational Diabetes - A Randomized, Controlled Trial PrEvention of PostPartum Diabetes Study (the PEPP Diabetes Study)

Run by Vastra Gotaland Region · NCT05112588 · Data updated 2026-11-12

This study is testing whether special support and encouragement can help women who had gestational diabetes avoid developing type 2 diabetes after giving birth.

More Gestational Diabetes trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexWomen only
Enrollment600 (estimated)
SponsorVastra Gotaland Region
Government
Locations1 site (Skövde)
StatusRecruiting
StartedNovember 1, 2021
Main results expectedDecember 31, 2025
Study endsDecember 31, 2030
Registry record updatedJune 13, 2024
Trial IDNCT05112588 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women who have been diagnosed with gestational diabetes and are willing to participate in follow-up care.

Probably not a fit

Patients with pre-existing diabetes or other endocrine disorders that affect blood glucose control may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on women diagnosed with gestational diabetes, aiming to prevent the development of type 2 diabetes postpartum. It involves a randomized clinical approach where participants will receive interventions designed to promote physical activity and adherence to follow-up care. The study addresses the challenges faced by women post-delivery, including the lack of compliance with glucose tolerance testing and follow-up recommendations. By implementing new diagnostic criteria and support systems, the study seeks to improve health outcomes for both mothers and their children.

Why it matters

Potential benefit: If successful, this study could significantly reduce the risk of type 2 diabetes in women who have experienced gestational diabetes.

How similar studies have gone: Other studies have shown success in similar approaches to managing gestational diabetes and preventing postpartum diabetes, indicating potential for positive outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Gestational diabetes
* Signed "Informed consent"
* Will be expected to participate in ordinary child health care.
* Access to Internet via computer, pad or phone

Exclusion Criteria:

* Manifest diabetes mellitus before pregnancy.
* Other conditions, e.g. endocrine disorders, or treatment, e.g. cortisone medication, that could affect blood glucose control
* Suspicion of type 1 diabetes mellitus as assessed by GAD antibodies or clinical history
* Participation in other concomitant research study that could interfere with the study parameters
* Other disease, treatment or condition that according to the Principal Investigator precludes participation

Where it's running

  • Maternity Ward, Västra Götaland
    Skövde, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.